{"id":"W4286295042","doi":"10.1200/jco.2022.40.16_suppl.8033","title":"Health-related quality of life in patients with relapsed/refractory multiple myeloma (RRMM) treated with teclistamab, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody: Patient-reported outcomes in MajesTEC-1.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Cohort; Visual analogue scale; Quality of life (healthcare); Refractory (planetary science); Progressive disease; Clinical trial; Oncology; Surgery; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006778887,0.0003160935,0.0006138605,0.0002864294,0.0003519157,0.0005785004,0.0002321581,0.0004584667,0.0008005987],"category_scores_gemma":[0.0006865524,0.000156205,0.0006417203,0.0004892045,0.0002119933,0.000384212,0.000373956,0.0007245406,0.0001743728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005451233,"about_ca_system_score_gemma":0.0003035589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001317165,"about_ca_topic_score_gemma":0.001976625,"domain_scores_codex":[0.9998063,0.00005699136,0.00001797648,0.00004025902,0.00002943644,0.00004897637],"domain_scores_gemma":[0.999522,0.00005948676,0.000184256,0.00001551331,0.00003651045,0.0001823354],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.03169883,0.003207877,0.9266867,0.0002449274,0.0006780902,0.0007375205,0.0004190393,0.001047616,0.004285959,0.00005179792,0.001527658,0.02941393],"study_design_scores_gemma":[0.001715719,0.02101848,0.9733115,0.00003607873,0.0003496232,0.0009501342,0.0001708932,0.001024283,0.0004554294,0.00004574583,0.0009020311,0.00001997634],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989012,0.000439154,0.00003380888,0.00005288963,0.000006053122,0.00003390797,0.000313115,0.000003118113,0.0002166827],"genre_scores_gemma":[0.998839,0.0001670414,0.00006798145,0.00009302781,0.00001399565,0.00003739999,0.0006579034,0.000001035229,0.0001226094],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001317165,"threshold_uncertainty_score":0.003955185,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09080855741906677,"score_gpt":0.4202928123343673,"score_spread":0.3294842549153005,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}